ClinicalTrials.gg
CompletedNCT00673400STARRUpdated Oct 2, 2012Results posted

Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM

An interventional study of Stapled transanal rectum resection in Obstructed Defecation Syndrome, Rectocele and Intussusception, sponsored by Cantonal Hospital of St. Gallen. Completed at 1 site in Switzerland. Per ClinicalTrials.gov, last updated 2012-10-02.

Sponsored by Cantonal Hospital of St. Gallen · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Not applicable
Sex
All
01

Study summary

The stapled transanal rectal resection (STARR procedure) is an effective treatment for obstructed defecation syndrome (ODS) caused by intussusception and rectocele. Recently a new technique has been developed using the new Contour® TranstarTM stapler, which was specifically designed to facilitate the STARR procedure. The investigators would like to evaluate the morbidity and quality of life.

02

Conditions studied

  • Obstructed Defecation Syndrome
  • Rectocele
  • Intussusception
  • SNS

Keywords

  • Obstructed defecation syndrome
  • ODS
  • Rectocele
  • Intussusception
  • STARR
03

In context

Rectocele

50 studies on the registry are indexed under Rectocele; 9 are open to participants now.

This study's enrollment of 52 is below the median of 62 across 37 interventional studies indexed under Rectocele.

Browse Rectocele studies →

Lead sponsor

Cantonal Hospital of St. Gallen is the lead sponsor of 79 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Rectocele
  • Intussusception

Exclusion criteria

Exclusion Criteria:

  • Non operability
  • inflammatory bowel disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
52 participants (actual)

Study arms

  • Other
    Stapled transanal rectum resection

    patients operated with stapled transanal rectum resection

    Procedure: Stapled transanal rectum resection

Interventions

  • ProcedureStapled transanal rectum resection

    Contour Transtar-STR5G (Ethicon EndoSurgery Inc., Cincinnati, OH).The circular anal dilator is fixed to perianal skin.Rectal intussusception is evidenced with a swab.The first stitch is placed superficial on top of the intussusception. The procedure is performed 5to6 times counterclockwise.A final stitch for first radial cut at 3 o'clock.The device is introduced into the rectum. This cut opens the prolapse. Check with a finger the vagina. The device is then closed and fired. After replacing the cartridge, the device is introduced in the rectum, placed parallel to the circular anal dilator and moved counter clockwise with 4to6firings to complete the resection. Additional stitches across the staple line to assure haemostasis.

06

What researchers measure

Primary outcomes

  1. Quality of Life

    Quality of life is measured by Fecal incontinence quality of life (FIQL) Possible range of score 0 - 4 (Depression/Self perception 4.4) 0 = worst condition * Fecal Incontinence Quality of Life (FIQL) (Rockwood, Dis Colon Rectum (2000) 43:9)

    Time frame: 6 months after intervention

Secondary outcomes

  1. Morbidity

    Surgical complications after treatment according to Dindo (Ann Surg (2004) 240:205)

    Time frame: 1 year

  2. Hospitalization

    Length of hospital stay (Date of release - Date of admission + 1)

    Time frame: 1 day to 1 year (until release from hospital)

Other outcomes

  1. Severity of Symptoms Score

    Score based on the severity of 9 symptoms of bowel movement (physician administered) (0 - 36, no symptoms = 0) Dis Colon Rectum 39:681 (DOI: 10.1007/BF02056950)

    Time frame: before surgery - 6 weeks - 3 months - 6 months

  2. Obstructive Defecation Syndrome Score

    Score based on severity or frequency of 9 symptoms of obstructive defecation (physician administered) (0 - 40, no symptoms = 0) Dis Colon Rectum 51:348(DOI: 10.1007/s10350-007-9115-1)

    Time frame: before surgery - 6 weeks -3 months - 6 months

  3. SF36 Component Summary Scores

    Quality of life short form 36 version 2(SF36v2) standard form PCS: physical component summary score (range 1 to 81, with 81 being the best) MCS: mental component summary score (range -9 to 82, with 82 being the best) A score of 50 correlates with the result of a healthy standard US population (score transformation to a mean of 50 and a standard deviation of 10) Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.

    Time frame: Before surgery - 6 months

07

Results

Posted Oct 2, 2012

Participant flow

Participant flow — Overall Study
MilestoneStapled TransAnal Rectal Resection
Started52
Completed52
Not completed0

Outcome measures

PrimaryQuality of Life

Quality of life is measured by Fecal incontinence quality of life (FIQL) Possible range of score 0 - 4 (Depression/Self perception 4.4) 0 = worst condition * Fecal Incontinence Quality of Life (FIQL) (Rockwood, Dis Colon Rectum (2000) 43:9)

Time frame:
6 months after intervention
Reported as:
Median · units on a scale
Quality of Life
units on a scaleBefore Surgery6 Months After Surgery
Lifestyle (LS)3.2 (2.4 to 3.6)3.7 (2.4 to 4.0)
Coping/behavior (C/P)2.8 (2.1 to 3.6)3.3 (2.2 to 4.0)
Depression/self-perception (D/S)3.3 (2.3 to 3.9)3.9 (3.1 to 4.1)
Embarrassment (E)3.3 (2.3 to 4.0)4.0 (3.7 to 4.0)
Statistical analysis
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.1340 (based on 28 pairwise matches)matched pair test, two-sided, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.088 (based on 29 matched pairs)matched pair test, two-sided, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.0012 (based on 30 matched pairs)matched pair test, two-sided, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.0074 (based on 30 matched pairs)matched pair test, two-sided, exact method
SecondaryMorbidity

Surgical complications after treatment according to Dindo (Ann Surg (2004) 240:205)

Time frame:
1 year
Reported as:
Number · participants
Morbidity
participantsStapled TransAnal Rectal Resection
overall6
Urinay retention (Dindo IIIa) (within 30 days)1
self limiting rectal bleeding (Dindo I)(6 weeks)2
Pain from residual staple (Dindo IIIa)(6 weeks)2
Perianal venous thrombosis (Dindo IIIa) (5 weeks)1
SecondaryHospitalization

Length of hospital stay (Date of release - Date of admission + 1)

Time frame:
1 day to 1 year (until release from hospital)
Reported as:
Median · days
Hospitalization
daysStapled TransAnal Rectal Resection
Hospitalization5 (2 to 29)
Other pre-specifiedSeverity of Symptoms Score

Score based on the severity of 9 symptoms of bowel movement (physician administered) (0 - 36, no symptoms = 0) Dis Colon Rectum 39:681 (DOI: 10.1007/BF02056950)

Time frame:
before surgery - 6 weeks - 3 months - 6 months
Reported as:
Median · units on a scale
Severity of Symptoms Score
units on a scaleBefore Surgery6 Weeks After Surgery3 Months After Surgery6 Months After Surgery
Severity of Symptoms Score15 (13 to 17)4 (2 to 5)3 (2 to 5)3 (2 to 5)
Statistical analysis
  • Before Surgery vs 6 Weeks After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
  • Before Surgery vs 3 Months After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
Other pre-specifiedObstructive Defecation Syndrome Score

Score based on severity or frequency of 9 symptoms of obstructive defecation (physician administered) (0 - 40, no symptoms = 0) Dis Colon Rectum 51:348(DOI: 10.1007/s10350-007-9115-1)

Time frame:
before surgery - 6 weeks -3 months - 6 months
Reported as:
Median · units on a scale
Obstructive Defecation Syndrome Score
units on a scaleBefore Surgery6 Weeks After Surgery3 Months After Surgery6 Months After Surgery
Obstructive Defecation Syndrome Score16 (14 to 18)5 (3 to 6)4 (3 to 5)5 (2 to 7)
Statistical analysis
  • Before Surgery vs 6 Weeks After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
  • Before Surgery vs 3 Months After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = <0.0000001two-sided, paired test, exact method
Other pre-specifiedSF36 Component Summary Scores

Quality of life short form 36 version 2(SF36v2) standard form PCS: physical component summary score (range 1 to 81, with 81 being the best) MCS: mental component summary score (range -9 to 82, with 82 being the best) A score of 50 correlates with the result of a healthy standard US population (score transformation to a mean of 50 and a standard deviation of 10) Ware JE, Kosinski M, Dewey JE. How to Score Version 2 of the SF-36® Health Survey. Lincoln, RI: QualityMetric Incorporated, 2000.

Time frame:
Before surgery - 6 months
Reported as:
Median · units on a scale
SF36 Component Summary Scores
units on a scaleBefore Surgery6 Months After Surgery
Physical component summary (PCS)51 (43 to 55)52 (35 to 55)
Mental component summary (MCS)39 (33 to 51)53 (40 to 58)
Statistical analysis
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.65 (based on 28 pairwise matches)matched pair test, two-sided, exact method
  • Before Surgery vs 6 Months After Surgery · Wilcoxon (Mann-Whitney) · p = 0.010 (based on 28 pairwise matches)matched pair test, two-sided, exact method

Adverse events

Collected over 1 year. Non-serious events are listed at a 1% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Stapled TransAnal Rectal Resection—0/52 (0%)4/52 (7.7%)
Most frequent other events
Most frequent other events
EventStapled TransAnal Rectal Resection
persisting pain due to residual staplesInjury, poisoning and procedural complications2/52
thrombosisBlood and lymphatic system disorders1/52
urinary retentionRenal and urinary disorders1/52

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Stapled TransAnal Rectal Resection
<=18 years0
Between 18 and 65 years29
>=65 years23
Age Continuous
Age Continuous(years)Stapled TransAnal Rectal Resection
Mean63.2 ± 12.9
Sex: Female, Male
Sex: Female, Male(Participants)Stapled TransAnal Rectal Resection
Female52
Male0
Region of Enrollment
Region of Enrollment(participants)Stapled TransAnal Rectal Resection
Switzerland52
08

Study locations

1 site
  • Department of Surgery, Cantonal Hospital St. Gallen
    St. Gallen, 9007, Switzerland
09

References and documents

Publications

  • Wolff K, Marti L, Beutner U, Steffen T, Lange J, Hetzer FH. Functional outcome and quality of life after stapled transanal rectal resection for obstructed defecation syndrome. Dis Colon Rectum. 2010 Jun;53(6):881-8. doi: 10.1007/DCR.0b013e3181cdb445. PubMed 20485001 ↗
10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2008, a primary completion of Nov 2008 and a completion of Nov 2009. It does not say whether these dates are actual or estimated.

Results were first posted in Oct 2012, 3 years 11 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
May 5, 2008
First posted
May 7, 2008
Start
Jan 2008
Primary completionActual
Nov 2008
CompletionActual
Nov 2009
Results first posted
Oct 2, 2012
Last update
Oct 2, 2012
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00673400
Lead sponsor
Cantonal Hospital of St. Gallen
Responsible party
F. Hetzer (Leitender Arzt, Cantonal Hospital of St. Gallen) — Principal investigator
First posted
May 7, 2008
Start date
Jan 2008
Primary completion
Nov 2008
Completion
Nov 2009
Results posted
Oct 2, 2012
Last update
Oct 2, 2012

Study contacts

Franc Hetzer, MD
principal investigator · Cantonal Hospital St. Gallen, Department of Surgery

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion